A phase II trial to study Unresectable stage III or stage IV melanoma
Cancer - Melanoma
John McCann, MD
D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
Baystate Franklin Medical Center
164 High Street
The purpose of this study is to compare overall survival for patients receiving ipilimumab plus bevacizumab versus ipilimumab alone.
Unresectable Stage III or Stage IV Melanoma; untreated or one previous treatment.